Med School: Separating Hype from Hope in Genome Science

Genomic discoveries were supposed to transform medicine and move us to a new vision of preventive health care. But 15 years after the Human Genome Project was complete, that still hasn’t happened. Meanwhile, direct-to-consumer genetics companies are bypassing health care providers to market ancestry, disease risk, diet, exercise and even dating and wine applications directly to the public. Robert Green, one of the world’s leaders in generating the evidence-base for genomic medicine, describes what's right and what’s wrong with the genomic revolution, and how we can realize the promise of precision medicine for all.
(Underwritten by America's Biopharmaceutical Companies)

Speakers: Robert C. Green
Festival: Spotlight Health 2018

Watch and Listen: Health

Health systems contribute significantly to the forces driving climate change, given the vast quantities of energy they... See more
Water is perhaps the world’s most precious and health-sustaining resource, and surely one most at risk. Microbes, lead... See more
Human beings swarm with bacteria, viruses, and fungi — trillions and trillions of them, inhabiting virtually every part... See more
Breakthrough research has revealed that the brain is especially open to change during specific periods in life –... See more
The Second City and Caring Across Generations have joined forces to develop a unique training program that strengthens... See more
Medical errors in hospitals rank as the third leading cause of death in the United States, exceeded only by cancer and... See more

Pages